BIMI International Medica... (BIMI)
OTC: BIMI
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Mar 14, 2025, 11:02 AM
BIMI International Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.52M | 5.56M | 3.2M | -5.43M | 7.31M | 2.83M | 5.02M | 1.88M | 13.78M | 9.26M | 2.17M |
Cost of Revenue | 2.41M | 2.67M | 1.51M | 2.32M | 5.73M | 2.36M | 3.56M | 1.87M | 11.75M | 7.29M | 1.58M |
Gross Profit | 115.16K | 2.88M | 1.69M | -7.75M | 1.58M | 472.58K | 1.46M | 10.19K | 2.03M | 1.96M | 592.26K |
Operating Income | -3.15M | 1.3M | 580.75K | -7.41M | -3.09M | -2.77M | -2.56M | -3.17M | -1.55M | -150.44K | -3.24M |
Interest Income | 53.00 | 68.00 | 261.00 | 91.00 | 293.00 | 207.00 | 146.00 | 3.1K | n/a | n/a | n/a |
Pretax Income | -3.13M | 1.17M | -860.63K | -11.05M | -3.71M | -6.14M | -2.72M | -29.66M | -1.7M | -262.48K | -3.27M |
Net Income | -3.13M | 1.05M | -884.21K | -11.03M | -3.71M | -6.54M | -2.74M | -29.67M | -1.7M | -275.99K | -3.33M |
Selling & General & Admin | 3.26M | 1.58M | 1.11M | -293.78K | 4.68M | 3.24M | 4.02M | 3.18M | 3.57M | 2.12M | 3.83M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | -25.37K | -1.41M | -575.92K | -469.72K | -2.55M | -50.32K | -264.66K | -74.3K | -18.16K | 12.87K |
Operating Expenses | 3.26M | 1.58M | 1.11M | -293.78K | 4.68M | 3.24M | 4.02M | 3.18M | 3.57M | 2.12M | 3.83M |
Interest Expense | 35.88K | 34.62K | 35.3K | 3.11M | 97.37K | 819.71K | 107.76K | 128.52K | 84.31K | 93.88K | 44.35K |
Selling & Marketing Expenses | 171.76K | 236.16K | 256.16K | -1.26M | 1.1M | 296.06K | 754.88K | 750.85K | 1.2M | 774.38K | 452.64K |
Cost & Expenses | 5.67M | 4.26M | 2.62M | -3.41M | 10.41M | 5.6M | 7.58M | 5.05M | 15.32M | 9.41M | 5.41M |
Income Tax Expense | n/a | 120.25K | 23.57K | -24.12K | -575 | 4.22K | 22.58K | -18.57K | 5.93K | 13.26K | 18.75K |
Shares Outstanding (Basic) | 6.43M | 4.6M | 3.83M | 2.66M | 2.32M | 9.49M | 1.01M | 541.69K | 541.69K | 474.14K | 333.86K |
Shares Outstanding (Diluted) | 6.43M | 4.6M | 3.83M | 2.66M | 2.32M | 9.49M | 1.01M | 541.69K | 541.69K | 474.14K | 333.86K |
EPS (Basic) | -0.49 | 0.23 | -0.23 | -4.14 | -1.6 | -0.69 | -2.72 | -54.78 | -3.14 | -0.58 | -9.98 |
EPS (Diluted) | -0.49 | 0.23 | -0.23 | -4.14 | -1.6 | -0.69 | -2.72 | -54.78 | -3.14 | -0.58 | -9.98 |
EBITDA | -3.11M | 1.28M | 580.75K | -7.88M | -2.38M | -2.28M | -2.06M | -30.38M | -1.56M | -67.6K | -3.19M |
EBIT | -3.1M | 1.21M | -825.34K | -7.94M | -2.29M | -5.32M | -2.15M | -29.54M | -1.62M | -168.6K | -3.23M |
Depreciation & Amortization | -17.36K | 74.34K | 53.8K | 58.32K | 35.29K | 36.98K | 89.16K | 64.97K | 60.34K | 192.54K | 56.68K |